Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

58.96
Delayed Data
As of Jul 31
 +0.68 / +1.17%
Today’s Change
41.72
Today|||52-Week Range
59.49
+39.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
AssetsCash918.4M2.1B2.3B860.3M
 
 
 
 
 
Short Term Investment Cash504.4M1.3B324.1M-1.2B
 
 
 
 
 
Cash & Short Term Investments1.2B2.3B2.6B1.1B
 
 
 
 
 
 
ReceivablesReceivables2.6B2.3B2.8B3.1B
 
 
 
 
 
 
InventoriesInventories2.0B1.9B1.8B1.8B
 
 
 
 
 
 
Current AssetsPrepaid Expenses----198.6M--
 
 
Other Current Assets522.7M508.4M40.8M353.6M
 
 
 
 
 
Current Assets6.3B7.0B7.5B6.2B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----7.7B--
 
 
Depreciation-----4.0B--
 
 
Intangible Assets313.9M237.2M223.9M197.2M
 
 
 
 
 
Other Assets313.9M237.2M223.9M197.2M
 
 
 
 
 
Total Assets11.7B12.1B12.5B11.1B
 
 
 
 
 
 
LiabilitiesAccounts Payable548.7M507.1M804.4M577.1M
 
 
 
 
 
Short Term Debt74.6M48.2M117.0M85.4M
 
 
 
 
 
Accrued Expenses----746.9M--
 
 
Other Current Liabilities3.5B4.0B3.3B4.9B
 
 
 
 
 
Other Liabilities4.4B5.1B5.5B6.0B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-803.7M-894.0M-876.2M-1.0B
 
 
 
 
 
Other Liabilities-0.00-0.000.000.00
 
 
 
 
Total Liabilities5.0B5.7B6.0B6.5B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity6.7B6.4B6.5B4.6B
 
 
 
 
 
Total Shareholder Equity6.7B6.4B6.5B4.6B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.1B2.1B2.1B2.1B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.